Captor Therapeutics Spolka Akcyjna (WSE:CTX)
72.90
-0.60 (-0.82%)
Jul 14, 2026, 5:04 PM CET
WSE:CTX Market Cap
WSE:CTX has a market cap or net worth of 466.97 million as of July 14, 2026. Its market cap has increased by 164.78% in one year.
Market Cap
466.97M
Enterprise Value
452.28M
Revenue
2.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
72.90
Market Cap Chart
Since April 19, 2021, WSE:CTX's market cap has decreased from 749.17M to 466.97M, a decrease of -37.67%. That is a compound annual growth rate of -8.63%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 14, 2026 | 463.16M | 16.35% |
| Dec 30, 2025 | 398.07M | 101.82% |
| Dec 30, 2024 | 197.24M | -57.12% |
| Dec 29, 2023 | 459.93M | -31.04% |
| Dec 30, 2022 | 666.90M | -10.15% |
| Dec 30, 2021 | 742.21M | -0.93% |
| Apr 19, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Syn2bio | 710.55M |
| Bioceltix | 513.39M |
| Ryvu Therapeutics | 369.92M |
| BIOTON | 328.00M |
| Synthaverse | 206.85M |
| Molecure | 121.56M |
| Mabion | 117.98M |
| Poltreg | 112.41M |